🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase Ib trial studies the side effects and best dose of telaglenastat...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2020-03-16
Trial ID
NCT03831932
This phase I trial studies the best dose of CB-839 HCl when given together ...
Status
Active Not Recruiting
Location
Yale University
Start Date
2019-07-08
Trial ID
NCT03798678
Treatments Being Tested
This phase I/Ib trial studies the side effects and best dose of CB-839 HCl ...
Status
Active Not Recruiting
Location
City of Hope Comprehensive Cancer Center
Start Date
2020-10-26
Trial ID
NCT04250545
Treatments Being Tested
This phase 1b trial studies the side effects and best dose of telaglenastat...
Status
Active Not Recruiting
Location
Mayo Clinic Hospital in Arizona
Start Date
2019-05-01
Trial ID
NCT03528642
Treatments Being Tested
This phase II trial studies how well glutaminase inhibitor telaglenastat hy...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2019-12-14
Trial ID
NCT03872427